Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

53.32
Delayed Data
As of Dec 12
 +0.90 / +1.72%
Today’s Change
32.83
Today|||52-Week Range
53.41
+48.69%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues14.9B15.7B16.0B16.6B
 
 
 
 
 
Cost of Goods Sold2.2B2.2B2.1B2.2B
 
 
 
 
 
Depreciation And Amortization473.5M495.6M387.4M393.1M
 
 
 
 
 
 
Operating ExpensesGross Income12.3B13.1B13.5B13.9B
 
 
 
 
 
General Expenses6.8B7.0B6.7B6.8B
 
 
 
 
 
Other Operating Expenses0.00113.3M0.000.00
 
 
Research And Development2.0B2.3B1.9B2.0B
 
 
 
 
 
Total Operating Expenses9.4B9.8B9.1B9.4B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income5.5B6.0B6.8B7.2B
 
 
 
 
 
Extraordinary Credit144.3M0.000.000.00
 
 
Extraordinary Charge-25.7M-321.0M-848.2M-116.1M
 
 
 
 
 
Interest Expense On Debt9.8M26.6M21.9M22.2M
 
 
 
 
 
Equity In Earnings0.000.002.1M3.6M
 
 
 
Other Expenses181.6M418.3M447.8M63.9M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income5.8B6.0B6.4B7.1B
 
 
 
 
 
Income Taxes-1.3B-1.3B-1.3B-1.5B
 
 
 
 
 
Net Income4.5B4.7B5.2B5.6B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.7B2.6B2.6B2.5B
 
 
 
 
 
Shares To Calculate EPS Diluted2.7B2.6B2.6B2.5B
 
 
 
 
 
 
Earnings Per ShareEPS$0.34$1.79$2.01$2.22
 
 
 
 
 
EPS Diluted$1.67$1.78$2.00$2.22